Next-generation immune cell therapies for lung cancer: advances in CAR-T, NK, and TIL strategies
Lung cancer remains the leading cause of cancer-related mortality worldwide, and current therapies offer limited survival benefit for patients with advanced disease. While immune checkpoint inhibitors and targeted therapies have improved outcomes in some populations, most patients either fail to res...
Zapisane w:
| Główni autorzy: | , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Frontiers Media S.A.
2026-03-01
|
| Seria: | Frontiers in Medicine |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.frontiersin.org/articles/10.3389/fmed.2026.1787086/full |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|